Related Experiment Video
Updated: Dec 9, 2025

Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
Published on: May 15, 2018
Glial Modulation of Electrical Rhythms in a Neuroglial Network Model of Epilepsy
Objective:
An important EEG-based biomarker for epilepsy is the phase-amplitude cross-frequency coupling (PAC) of electrical rhythms; however, the underlying pathways of these pathologic markers are not always clear. Since glial cells have been shown to play an active role in neuroglial networks, it is likely that some of these PAC markers are modulated via glial effects.
Methods:
We developed a 4-unit hybrid model of a neuroglial network, consisting of 16 sub-units, that combines a mechanistic representation of neurons with an oscillator-based Cognitive Rhythm Generator (CRG) representation of glial cells-astrocytes and microglia. The model output was compared with recorded generalized tonic-clonic patient data, both in terms of PAC features, and state classification using an unsupervised hidden Markov model (HMM).
Results:
The neuroglial model output showed PAC features similar to those observed in epileptic seizures. These generated PAC features were able to accurately identify spontaneous epileptiform discharges (SEDs) as seizure-like states, as well as a postictal-like state following the long-duration SED, when applied to the HMM machine learning algorithm trained on patient data. The evolution profile of the maximal PAC during the SED compared well with patient data, showing similar association with the duration of the postictal state.
Conclusion:
The hybrid neuroglial network model was able to generate PAC features similar to those observed in ictal and postictal epileptic states, which has been used for state classification and postictal state duration prediction.
Significance:
Since PAC biomarkers are important for epilepsy research and postictal state duration has been linked with risk of sudden unexplained death in epilepsy, this model suggests glial synaptic effects as potential targets for further analysis and treatment.
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Overview of Synapses

